Grissom Exits Boston Scientific Beltway; Polymer Traffic To Continue
This article was originally published in The Gray Sheet
Boston Scientific VP-Federal Affairs, Reimbursement & Outcomes Planning Randel Richner will direct Washington, D.C. operations on a temporary basis, now that Tom Grissom has left the firm
You may also be interested in...
CMS remains open to considering whether inpatient diagnosis-related groups (DRGs) for drug-eluting stents should reflect differences in the number of stents implanted and/or vessels treated
CMS' "coverage with evidence development" (CED) draft guidance appears to venture into FDA's traditional jurisdiction of evaluating safety and effectiveness
AdvaMed member companies who are not represented on the group's executive search committee are circulating a list of potential replacements for President Pam Bailey